1 Lechien JR,Akst M,Hamdan AL,et al.Evaluation and management of laryngopharyngeal reflux disease:state of the art review[J].Otolaryngol Head Neck Surg,2019,160(5):762-782.

2 Xiao SF,Li JR,Zheng HL,et al.An epidemiological survey of laryngopharyngeal reflux disease at the otorhinolaryngology-head and neck surgery clinics in China[J].Eur Arch Otorhinolaryngol,2020,277(10):2829-2838.

3 Wang J,Zhao Y,Ren JJ,et al.Heat shock protein 70 is induced by pepsin via MAPK signaling in human nasal epithelial cells[J].Eur Arch Otorhinolaryngol,2019,276(3):767-774.

4 Szczesniak MM,Williams RB,Cook IJ,Mechanisms of esophago-pharyngeal acid regurgitation in human subjects[J].PLoS One,2011,6(7):e22630.

5 Lang IM,Medda BK,Shaker R.Effects of esophageal acidification on esophageal reflexes controlling the upper esophageal sphincter[J].Am J Physiol Gastrointest Liver Physiol,2019,316(1):G45-G54.

6 Postma GN,Tomek MS,Belafsky PC,et al.Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease[J].Ann Otol Rhinol Laryngol,2001,110(12):1114-1116.

7 Wang AM,Wang G,Huang N,et al.Association between laryngopharyngeal reflux disease and autonomic nerve dysfunction[J].Eur Arch Otorhinolaryngol,2019,276(8):2283-2287.

8 Díaz VT,Elli EF.Clinical outcomes of gastroesophageal reflux disease-related chronic cough following antireflux fundoplication[J].Esophagus,2020,17(1):92-98.

9 Johnston N,Knight J,Dettmar PW,et al.Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease[J].Laryngoscope,2004,114(12):2129-2134.

10 Min HJ,Hong SC,Yang HS,et al.Expression of CAIII and Hsp70 is increased the mucous membrane of the posterior commissure in laryngopharyngeal reflux disease[J].Yonsei Med J,2016,57(2):469-474.

11 Wood JM,Hussey DJ,Woods CM,et al.Does gene expression in laryngeal subsites differ between patients with laryngopharyngeal reflux and controls[J]?Clin Otolaryngol,2018,43(1):158-163.

12 Hoppo T,Zaidi AH,Matsui D,et al.Sep70/pepsin expression in hypopharynx combined with hypopharyngeal multichannel intraluminal impedance increases diagnostic sensitivity of laryngopharyngeal reflux[J].Surg Endosc,2018,32(5):2434-2441.

13 王嘉森，李进让.咽喉反流在任克间隙水肿发病中的作用[J].临床耳鼻咽喉头颈外科杂志，2016,30(24):1931-1934.

14 陈伟，季寒，吴明海，等.抑酸治疗对声带白斑术后相关症状的影响[J].医学研究生学报，2017,30(1):66-69.

15 Chong VH,Jalihal A.Heterotopic gastric mucosal patch of the esophagus is associated with higher prevalence of laryngopharyngeal reflux symptoms[J].Eur Arch Otorhinolaryngol,2010,267(11):1793-1799.

16 Koufman JA.The otolaryngologic manifestations of gastroesophageal reflux disease (GERD):a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury[J]?Laryngoscope,1991,101:1-78.

17 Johnston N,Wells CW,Samuels TL,et al.Rationale for targeting pepsin in the treatment of reflux disease[J].Ann Otol Rhinol Laryngol,2010,119(8):547-58.

18 Samuels TL,Zimmermann MT,Zeighami A,et al.RNA sequencing reveals cancer-associated changes in laryngeal cells exposed to non-acid pepsin[J].Laryngoscope,2021,131(1):121-129.

19 Peyvandi H,Peyvandi AA,Safaei A,et al.Introducing potential key proteins and pathways in human laryngeal cancer:a system biology approach[J].Iran J Pharm Res,2018,17(1):415-425.

20 Tan JJ,Wang L,Mo TT,et al.Pepsin promotes IL-8 signaling-induced epithelial-mesenchymal transition in laryngeal carcinoma[J].Cancer Cell Int,2019,19:64.

21 Parsel SM,Wu EL,Riley CA,et al.Gastroesophageal and laryngopharyngeal reflux associated with laryngeal malignancy:a systematic review and meta-analysis[J].Clin Gastroenterol Hepatol,2019,17(7):1253-1264.e5.

22 Riley CA,Marino MJ,Hsieh MC,et al.Detection of laryngeal carcinoma in the U.S.elderly population with gastroesophageal reflux disease[J].Head Neck,2019,41(5):1434-1440.

23 Niu K,Guo CJ,Teng SY,et al.Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation[J].PLoS One,2020,15(1):e0227408.

24 Li JR,Wang JS,Wu MK,et al.The role of nonacid reflux in laryngopharyngeal reflux diseases[J].Eur Arch Otorhinolaryngol,2020,277(10):2813-2819.

25 Sasaki CT,Doukas SG,Costa J,et al.Biliary reflux as a causal factor in hypopharyngeal carcinoma:new clinical evidence and implications[J].Cancer,2019,125(20):3554-3565.

26 Singh GB,Yvette WG,Shukla S,et al.The role of helicobacter pylori and laryngopharyngeal reflux in recurrent tonsillitis[J].Int J Pediatr Otorhinolaryngol,2020,138:110376.

27 Youssef TF,Ahmed MR,Treatment of clinically diagnosed laryngopharyngeal reflux disease[J].Arch Otolaryngol Head Neck Surg,2010,136(11):1089-1092.

28 Siupsinskiene N,Katutiene I,Jonikiene V,et al.Helicobacter pylori in the tonsillar tissue:a possible association with chronic tonsillitis and laryngopharyngeal reflux[J].J Laryngol Otol,2017,131(6):549-556.

29 Siupsinskiene N,Katutiene I,Jonikiene V,et al.Intranasal helicobacter pylori infection in patients with chronic rhinosinusitis with polyposis[J].J Laryngol Otol,2018,132(9):816-821.

30 Kumral TL,G?kden Y,Saltürk Z,et al.The effect of gastric helicobacter pylori colonization on nasal functions[J].Ear Nose Throat J,2019,98(6):346-350.

31 刘倩，吕颜露.咽喉反流通过NF-κB信号通路介导炎症反应对声带黏膜的影响[J].华中科技大学学报(医学版),2019,48(1):32-37.

32 郑宏良，陈东辉.咽喉反流疾病的诊治亟待规范[J].中华耳鼻咽喉头颈外科杂志，2013,48(6):441-444.